Showing results (261-270 of 343) with videos related to
Sort By:
Pageof 35
Journal of Pediatric Gastroenterology and Nutrition|December 17, 2016
Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology CommitteesLawrence J Saubermann, Mark Deneau, Richard A Falcone, et al.Frontiers in Oncology|August 16, 2023
Multiomic analysis of HER2-enriched and AR-positive breast carcinoma with apocrine differentiation and an oligometastatic course: a case reportBrando Poggiali, Agostino Ponzetti, Marica Malerba, et al.ESMO Open|October 24, 2021
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONOD Rossini, A Boccaccino, A Sbrana, et al.The Pharmacogenomics Journal|March 2, 2016
Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancerF Graziano, A Ruzzo, E Giacomini, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trialG Masi, L Salvatore, L Boni, et al.British Journal of Cancer|November 24, 2004
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 studyC Gridelli, C Gallo, M Di Maio, et al.Plos One|August 31, 2023
Using individual-based bioenergetic models to predict the aggregate effects of disturbance on populations: A case study with beaked whales and Navy sonarVincent Hin, André M de Roos, Kelly J Benoit-Bird, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2012
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?D Santini, B Vincenzi, R Addeo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working PartyG D'Arena, C G Valentini, G Pietrantuono, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Tumor targeting by intra-arterial infusion of 5-[123I]iodo-2'-deoxyuridine in patients with liver metastases from colorectal cancerG Mariani, S Di Sacco, D Volterrani, et al.Pageof 35